前列腺癌患者淋巴结受累概率预测模型的外部验证
本研究在1001例接受扩大盆腔淋巴结清扫术的荷兰前列腺癌患者中外部验证了16个预测淋巴结受累(LNI)的模型。276例(28%)存在淋巴结受累。2012年Briganti列线图(AUC 0.76)和纪念斯隆凯特琳癌症中心(MSKCC)网络计算器(AUC 0.75)预测最准确,校准在模型选择中起决定性作用。
要点
- 在1001例接受扩大盆腔淋巴结清扫术的荷兰前列腺癌患者中,276例(28%)存在淋巴结受累。
- 2012年Briganti列线图(AUC 0.76)和MSKCC网络计算器(AUC 0.75)预测最准确。
- 模型在预测概率低于20%的患者中低估了淋巴结受累概率。
核心结论
- 在前列腺癌患者中预测淋巴结受累的模型在荷兰患者队列中进行了外部验证,2012年Briganti列线图和MSKCC列线图被确定为最准确的预测模型。
研究设计与样本
- 研究使用1001例接受扩大盆腔淋巴结清扫术的男性患者队列,对16个预测淋巴结受累的模型进行外部验证。
主要发现
- 276例患者(28%)存在淋巴结受累。
- 存在淋巴结受累的患者相比无淋巴结受累的患者,血清前列腺特异性抗原(PSA)更高、主要Gleason分级更高、Gleason评分更高、获取淋巴结数更多、阳性活检针数更多、cT分期更高。
- 2012年Briganti列线图(AUC 0.76)和纪念斯隆凯特琳癌症中心(MSKCC)网络计算器(AUC 0.75)的预测最准确。
- 由于AUC的置信区间重叠,校准在選擇最准确模型时具有决定性作用。
- 模型在预测概率低于20%的患者中低估了淋巴结受累概率。
局限性
- 未进行模型更新是本研究的一个局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multiple statistical models predicting lymph node involvement (LNI) in prostate cancer (PCa) exist to support clinical decision-making regarding extended pelvic lymph node dissection (ePLND). OBJECTIVE: To validate models predicting LNI in Dutch PCa patients. DESIGN, SETTING, AND PARTICIPANTS: Sixteen prediction models were validated using a patient cohort of 1001 men who underwent ePLND. Patient characteristics included serum prostate specific antigen (PSA), cT stage, primary and secondary Gleason scores, number of biopsy cores taken, and number of positive biopsy cores. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Model performance was assessed using the area under the receiver operating characteristic curve (AUC). Calibration plots were used to visualize over- or underestimation by the models. RESULTS AND LIMITATIONS: LNI was identified in 276 patients (28%). Patients with LNI had higher PSA, higher primary Gleason pattern, higher Gleason score, higher number of nodes harvested, higher number of positive biopsy cores, and higher cT stage compared to patients without LNI. Predictions generated by the 2012 Briganti nomogram (AUC 0.76) and the Memorial Sloan Kettering Cancer Center (MSKCC) web calculator (AUC 0.75) were the most accurate. Calibration had a decisive role in selecting the most accurate models because of overlapping confidence intervals for the AUCs. Underestimation of LNI probability in patients had a predicted probability of <20%. The omission of model updating was a limitation of the study. CONCLUSIONS: Models predicting LNI in PCa patients were externally validated in a Dutch patient cohort. The 2012 Briganti and MSKCC nomograms were identified as the most accurate prediction models available. PATIENT SUMMARY: In this report we looked at how well models were able to predict the risk of prostate cancer spreading to the pelvic lymph nodes. We found that two models performed similarly in predicting the most accurate probabilities.
引用
- Hueting TA, Cornel EB, Somford DM, et al. External Validation of Models Predicting the Probability of Lymph Node Involvement in Prostate Cancer Patients. Eur Urol Oncol. 2018. PMID: 31158080. doi:10.1016/j.euo.2018.04.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。